RGS1 has been identified as the gene with the highest immune relevance in the RGS family, and RGS1 inherent in tumours is able to participate in the regulation of various intracellular biological processes, enhance tumour immunogenicity and anti‐tumour immune responses, and reverse immune resistance.47 The gene discussed is PITX2; the disease is neoplasm.